{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Dayton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "95993",
      "recalling_firm": "Hikma Injectables USA Inc",
      "address_1": "36 Stults Rd",
      "address_2": "",
      "postal_code": "08810-1540",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0174-2025",
      "product_description": "phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25",
      "product_quantity": "",
      "reason_for_recall": "Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.",
      "recall_initiation_date": "20241219",
      "center_classification_date": "20250102",
      "termination_date": "20251112",
      "report_date": "20250108",
      "code_info": "Lot number: 243120003D, Use by Date: 03/11/2025",
      "more_code_info": ""
    }
  ]
}